Sector Gamma AS Has $5.48 Million Stake in GE HealthCare Technologies Inc. $GEHC

Key Points

• Sector Gamma AS increased its stake in GE HealthCare Technologies by 19.4%, owning 74,000 shares valued at approximately $5.48 million, making it the 22nd largest position in its investment portfolio.
• GE HealthCare Technologies reported Q2 earnings of $1.06 per share, exceeding estimates of $0.91, with quarterly revenue of $5 billion, up 3.5% from the previous year.
• The company declared a quarterly dividend of $0.035 per share, with an annualized dividend yield of 0.2%, to be paid on November 14th.

Sector Gamma AS boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 19.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,000 shares of the company's stock after buying an additional 12,000 shares during the quarter. GE HealthCare Technologies makes up about 1.8% of Sector Gamma AS's investment portfolio, making the stock its 22nd largest position. Sector Gamma AS's holdings in GE HealthCare Technologies were worth $5,481,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also bought and sold shares of the company. Bessemer Group Inc. boosted its stake in GE HealthCare Technologies by 24.3% in the 1st quarter. Bessemer Group Inc. now owns 6,671 shares of the company's stock valued at $538,000 after buying an additional 1,306 shares in the last quarter. Flagship Harbor Advisors LLC boosted its stake in GE HealthCare Technologies by 17.4% in the 1st quarter. Flagship Harbor Advisors LLC now owns 3,443 shares of the company's stock valued at $278,000 after buying an additional 511 shares in the last quarter. Lineweaver Wealth Advisors LLC acquired a new stake in GE HealthCare Technologies in the 2nd quarter valued at $592,000. Wealth Enhancement Advisory Services LLC boosted its stake in GE HealthCare Technologies by 23.8% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 50,859 shares of the company's stock valued at $4,105,000 after buying an additional 9,769 shares in the last quarter. Finally, Exome Asset Management LLC acquired a new stake in GE HealthCare Technologies in the 1st quarter valued at $2,050,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Trading Up 1.5%

Shares of GEHC opened at $77.26 on Friday. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The firm has a market capitalization of $35.27 billion, a PE ratio of 15.83, a price-to-earnings-growth ratio of 2.91 and a beta of 1.13. The stock's fifty day simple moving average is $74.68 and its 200-day simple moving average is $72.30.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same quarter in the prior year, the firm posted $1.00 earnings per share. The firm's revenue for the quarter was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies's dividend payout ratio is 2.87%.

Analyst Upgrades and Downgrades

GEHC has been the topic of a number of recent analyst reports. Barclays initiated coverage on GE HealthCare Technologies in a research note on Monday, October 13th. They issued an "equal weight" rating and a $86.00 price objective on the stock. BTIG Research boosted their price objective on GE HealthCare Technologies from $87.00 to $89.00 and gave the stock a "buy" rating in a research note on Monday, October 13th. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a research note on Thursday, September 18th. Wall Street Zen lowered GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, September 20th. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of GE HealthCare Technologies in a research note on Tuesday, October 14th. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, GE HealthCare Technologies has an average rating of "Moderate Buy" and an average price target of $85.20.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.